Technical Analysis for GANX - Gain Therapeutics, Inc.

Grade Last Price % Change Price Change
C 14.5 2.84% 0.40
GANX closed up 2.84 percent on Friday, April 16, 2021, on 58 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical GANX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Bullish Engulfing Bullish 3.42%
Outside Day Range Expansion 3.42%
Shooting Star Candlestick Bearish 3.57%
Lizard Bearish Bearish Day Trade Setup 3.57%
Pocket Pivot Bullish Swing Setup 3.57%
Wide Range Bar Range Expansion 3.57%
Older End-of-Day Signals for GANX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support 1 day ago
Rose Above 10 DMA 1 day ago
Down 1% 1 day ago
10 DMA Resistance 1 day ago
1.5x Volume Pace 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Gain Therapeutics, Inc., a development stage biotechnology company, develops novel therapeutics to treat rare genetic and neurological disorders caused by protein misfolding in Switzerland and Spain. The company through its in-licensed proprietary Site-Directed Enzyme Enhancement Therapy platform, discovers novel allosteric sites on misfolded proteins, identifies proprietary binding sites, and restores protein folding. It has a research collaboration agreement with Sumitomo Dainippon Pharma Co., Ltd. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was founded in 2017 and is based in Bethesda, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Allosteric Regulation Sumitomo Group

Is GANX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.93
52 Week Low 11.0
Average Volume 161,347
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 13.91
10-Day Moving Average 14.28
Average True Range 1.47
ADX 0.0
+DI 30.88
-DI 10.79
Chandelier Exit (Long, 3 ATRs ) 13.53
Chandelier Exit (Short, 3 ATRs ) 15.40
Upper Bollinger Band 15.93
Lower Bollinger Band 11.89
Percent B (%b) 0.65
BandWidth 29.06
MACD Line 0.21
MACD Signal Line 0.18
MACD Histogram 0.039
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.63
Resistance 3 (R3) 15.55 15.11 15.44
Resistance 2 (R2) 15.11 14.82 15.14 15.37
Resistance 1 (R1) 14.80 14.64 14.58 14.88 15.31
Pivot Point 14.36 14.36 14.25 14.39 14.36
Support 1 (S1) 14.05 14.07 13.83 14.13 13.69
Support 2 (S2) 13.61 13.89 13.64 13.63
Support 3 (S3) 13.30 13.61 13.56
Support 4 (S4) 13.38